| id | C00002993 |
|---|---|
| Name | Haematoxylin |
| CAS RN | 517-28-2 |
| Standard InChI | InChI=1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2/t13-,16+/m0/s1 |
| Standard InChI (Main Layer) | InChI=1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2 |
| Phytochemical cluster | |
|---|---|
| KCF-S cluster | No. 1670 |
| By standard InChI | CHEMBL477197 |
|---|---|
| By standard InChI Main Layer | CHEMBL477197 CHEMBL1448387 CHEMBL1479103 |
| By LinkDB | C09931 |
|---|
| By CAS RN | D006416 |
|---|
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Haematoxylon compechianum | ||||
| Haematoxylum campechianum | 321551 | Fabaceae | rosids | Viridiplantae |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL1479103 |
CHEMBL1613992
(1)
CHEMBL1613995
(1)
|
7 / 44 |
| Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | CHEMBL1479103 |
CHEMBL1614529
(1)
|
0 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL1479103 |
CHEMBL1613842
(1)
|
4 / 2 |
| Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1738312
(2)
|
0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | CHEMBL1448387 CHEMBL1479103 |
CHEMBL2114784
(2)
|
1 / 1 |
| P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1794499
(2)
|
2 / 0 |
| Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL1448387 |
CHEMBL1794573
(1)
|
2 / 2 |
| P06746 | DNA polymerase beta | Enzyme | CHEMBL1479103 |
CHEMBL1614079
(1)
|
0 / 0 |
| P21802 | Fibroblast growth factor receptor 2 | TK tyrosine-protein kinase TLK subfamily | CHEMBL477197 |
CHEMBL986526
(1)
|
9 / 3 |
| P04062 | Glucosylceramidase | Enzyme | CHEMBL1479103 |
CHEMBL1613818
(1)
|
6 / 4 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL1479103 |
CHEMBL1614076
(1)
|
1 / 1 |
| Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL1479103 |
CHEMBL1794585
(1)
|
0 / 0 |
| Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | CHEMBL1479103 |
CHEMBL1614153
(1)
|
1 / 4 |
| P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL1448387 |
CHEMBL1614281
(1)
CHEMBL1614361
(1)
|
3 / 2 |
| Q00535 | Cyclin-dependent kinase 5 | Cdk5 | CHEMBL1479103 |
CHEMBL1738240
(1)
|
0 / 0 |
| Q15078 | Cyclin-dependent kinase 5 activator 1 | REG serine/threonine protein kinase family | CHEMBL1479103 |
CHEMBL1738240
(1)
|
0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL477197 |
CHEMBL986505
(1)
CHEMBL986517
(1)
|
1 / 11 |
| P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL477197 CHEMBL1448387 CHEMBL1479103 |
CHEMBL1794311
(4)
|
2 / 3 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1613800
(3)
|
0 / 0 |
| P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL477197 |
CHEMBL986504
(1)
CHEMBL986516
(1)
|
0 / 0 |
| P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1614458
(3)
|
0 / 0 |
| P39748 | Flap endonuclease 1 | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1794486
(3)
|
0 / 0 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1738606
(2)
|
0 / 0 |
| P11413 | Glucose-6-phosphate 1-dehydrogenase | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1737961
(2)
|
1 / 2 |
| O75496 | Geminin | Unclassified protein | CHEMBL1479103 |
CHEMBL2114843
(1)
CHEMBL2114780
(1)
|
0 / 0 |
| P10145 | Interleukin-8 | Secreted protein | CHEMBL1448387 |
CHEMBL2114835
(1)
|
0 / 0 |
| P29323 | Ephrin type-B receptor 2 | Eph | CHEMBL477197 |
CHEMBL986510
(1)
CHEMBL986520
(1)
|
2 / 0 |
| Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1794569
(2)
|
1 / 1 |
| P09923 | Intestinal-type alkaline phosphatase | Enzyme | CHEMBL1479103 |
CHEMBL1738315
(1)
|
0 / 0 |
| P49023 | Paxillin | Unclassified protein | CHEMBL477197 |
CHEMBL986522
(1)
|
0 / 0 |
| P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | CHEMBL1479103 |
CHEMBL1738614
(1)
|
3 / 1 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1614280
(2)
|
0 / 0 |
| P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1794401
(2)
|
0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL1479103 |
CHEMBL1794467
(1)
|
0 / 0 |
| P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL1448387 |
CHEMBL1794382
(1)
|
0 / 1 |
| P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL1448387 |
CHEMBL1794510
(1)
|
5 / 3 |
| P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL477197 |
CHEMBL986502
(1)
CHEMBL986514
(1)
CHEMBL986523 (1) CHEMBL986524 (1) CHEMBL986525 (1) CHEMBL986527 (1) |
5 / 10 |
| P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | CHEMBL477197 |
CHEMBL986499
(1)
CHEMBL986511
(1)
CHEMBL986521 (1) |
0 / 0 |
| P35968 | Vascular endothelial growth factor receptor 2 | Vegfr | CHEMBL477197 |
CHEMBL986503
(1)
CHEMBL986515
(1)
|
1 / 0 |
| Q96RI1 | Bile acid receptor | NR1H4 | CHEMBL1448387 |
CHEMBL1794437
(1)
|
0 / 0 |
| P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | CHEMBL477197 |
CHEMBL986500
(1)
CHEMBL986512
(1)
|
2 / 3 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL477197 CHEMBL1479103 |
CHEMBL1614521
(3)
CHEMBL1613808
(1)
|
0 / 0 |
| P10696 | Alkaline phosphatase, placental-like | Enzyme | CHEMBL1479103 |
CHEMBL1738514
(1)
|
0 / 1 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1613910
(3)
CHEMBL1614227
(1)
|
3 / 3 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL477197 CHEMBL1448387 CHEMBL1479103 |
CHEMBL1614038
(4)
|
2 / 2 |
| P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | CHEMBL1448387 |
CHEMBL2114842
(1)
|
0 / 0 |
| P11362 | Fibroblast growth factor receptor 1 | Fgfr | CHEMBL477197 |
CHEMBL986501
(1)
CHEMBL986513
(1)
|
4 / 5 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL1479103 |
CHEMBL1614240
(1)
|
0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1614108
(3)
CHEMBL1613886
(3)
|
0 / 1 |
| Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1794483
(3)
|
0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1737991
(2)
|
0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL477197 CHEMBL1448387 CHEMBL1479103 |
CHEMBL1614211
(3)
|
0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL477197 CHEMBL1448387 CHEMBL1479103 |
CHEMBL1614250
(4)
CHEMBL1614421
(4)
CHEMBL1614502 (4) |
4 / 3 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1738184
(2)
CHEMBL2114890
(1)
|
0 / 0 |
| P10275 | Androgen receptor | NR3C4 | CHEMBL1448387 |
CHEMBL1794560
(1)
|
3 / 4 |
| P10721 | Mast/stem cell growth factor receptor Kit | Pdgfr | CHEMBL477197 |
CHEMBL986509
(1)
CHEMBL986519
(1)
|
4 / 4 |
| P34949 | Mannose-6-phosphate isomerase | Enzyme | CHEMBL1479103 |
CHEMBL1614255
(1)
|
1 / 1 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL1794536
(5)
|
0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL477197 CHEMBL1448387 CHEMBL1479103 |
CHEMBL1613914
(4)
|
0 / 0 |
| P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL477197 CHEMBL1448387 CHEMBL1479103 |
CHEMBL1613829
(3)
CHEMBL1794433
(1)
|
0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL1479103 |
CHEMBL1738442
(1)
|
0 / 0 |
| Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL477197 CHEMBL1448387 CHEMBL1479103 |
CHEMBL1614364
(6)
|
1 / 1 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL1448387 |
CHEMBL2354311
(1)
|
1 / 0 |
| Q8IUX4 | DNA dC->dU-editing enzyme APOBEC-3F | Enzyme | CHEMBL1479103 |
CHEMBL1963966
(1)
|
0 / 0 |
| O00255 | Menin | Unclassified protein | CHEMBL1479103 |
CHEMBL1614257
(1)
CHEMBL1614531
(1)
|
2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL1479103 |
CHEMBL1614257
(1)
CHEMBL1614531
(1)
|
1 / 3 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL477197 |
CHEMBL1613933
(1)
|
0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL477197 |
CHEMBL1613933
(1)
|
1 / 6 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL1448387 |
CHEMBL2114738
(1)
|
0 / 0 |
| Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | CHEMBL1448387 CHEMBL1479103 |
CHEMBL2114796
(2)
|
2 / 1 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #300068 | Androgen insensitivity syndrome; ais |
P10275
|
| #312300 | Androgen insensitivity, partial; pais |
P10275
|
| #300908 | Anemia, nonspherocytic hemolytic, due to g6pd deficiency |
P11413
|
| #207410 | Antley-bixler syndrome without genital anomalies or disordered steroidogenesis; abs2 |
P21802
|
| #101200 | Apert syndrome |
P21802
|
| #208900 | Ataxia-telangiectasia; at |
Q13315
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #123790 | Beare-stevenson cutis gyrata syndrome; bstvs |
P21802
|
| #614592 | Bent bone dysplasia syndrome; bbds |
P21802
|
| %606641 | Body mass index; bmi |
P37231
|
| #609338 | Carotid intimal medial thickness 1 |
P37231
|
| #114500 | Colorectal cancer; crc |
Q14191
|
| #602579 | Congenital disorder of glycosylation, type ib; cdg1b |
P34949
|
| #123500 | Crouzon syndrome |
P21802
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #133239 | Esophageal cancer |
P04637
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #613659 | Gastric cancer |
P04626
|
| #137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
| #606764 | Gastrointestinal stromal tumor; gist |
P10721
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
| #232300 | Glycogen storage disease ii |
P10253
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #602089 | Hemangioma, capillary infantile |
P35968
|
| #114550 | Hepatocellular carcinoma |
P08581
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #603373 | Hyperthyroidism, familial gestational |
P16473
|
| #609152 | Hyperthyroidism, nonautoimmune |
P16473
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #147950 | Hypogonadotropic hypogonadism 2 with or without anosmia; hh2 |
P11362
|
| #146300 | Hypophosphatasia, adult |
P05186
|
| #241510 | Hypophosphatasia, childhood |
P05186
|
| #241500 | Hypophosphatasia, infantile |
P05186
|
| #275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
| #123150 | Jackson-weiss syndrome; jws |
P21802
|
| #149730 | Lacrimoauriculodentodigital syndrome; ladd |
P21802
|
| #601626 | Leukemia, acute myeloid; aml |
P10721
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
| #613688 | Long qt syndrome 2; lqt2 |
Q12809
|
| #211980 | Lung cancer |
P00533
P04626 P04637 |
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #601665 | Obesity |
P37231
|
| #166250 | Osteoglophonic dysplasia; ogd |
P11362
|
| #167000 | Ovarian cancer |
P04626
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #101600 | Pfeiffer syndrome |
P11362
P21802 |
| #172700 | Pick disease of brain |
P10636
|
| #172800 | Piebald trait; pbt |
P10721
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #176807 | Prostate cancer |
P29323
|
| #603688 | Prostate cancer/brain cancer susceptibility |
P29323
|
| #605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
| #609579 | Scaphocephaly, maxillary retrusion, and mental retardation |
P21802
|
| #604906 | Schizophrenia 9; sczd9 |
P49798
|
| #181500 | Schizophrenia; sczd |
P49798
|
| #609620 | Short qt syndrome 1; sqt1 |
Q12809
|
| #313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #273300 | Testicular germ cell tumor; tgct |
P10721
|
| #190440 | Trigonocephaly 1; trigno1 |
P11362
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| #277700 | Werner syndrome; wrn |
Q14191
|
| #278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) |
| H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P08581 (related) P21802 (related) |
| H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
| H00028 | Choriocarcinoma |
P00533
(related)
P04626 (related) P04637 (related) |
| H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
| H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
| H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
| H00026 | Endometrial Cancer |
P04626
(related)
P04637 (related) |
| H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
| H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
| H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P08581 (related) |
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
Q13315 (related) |
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
|
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
| H00038 | Malignant melanoma |
P04637
(related)
|
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
|
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
P08581 (related) |
| H00213 | Hypophosphatasia |
P05186
(related)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00024 | Prostate cancer |
P10275
(related)
|
| H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
| H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
| H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00023 | Testicular cancer |
P10696
(marker)
P10721 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
P10721
(related)
P10721 (marker) Q01196 (related) Q01196 (marker) Q13951 (marker) |
| H00170 | Piebaldism |
P10721
(related)
|
| H00255 | Hypogonadotropic hypogonadism |
P11362
(related)
|
| H00443 | Osteoglophonic dysplasia (OD) |
P11362
(related)
|
| H00458 | Craniosynostosis |
P11362
(related)
P21802 (related) |
| H00516 | Isolated orofacial clefts |
P11362
(related)
|
| H01207 | Trigonocephaly |
P11362
(related)
|
| H00101 | Other phagocyte defects |
P11413
(related)
|
| H00668 | Anemia due to disorders of glutathione metabolism |
P11413
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
| H01269 | Congenital hyperthyroidism |
P16473
(related)
|
| H00642 | Lacrimo-auriculo-dento-digital syndrome (LADD) |
P21802
(related)
|
| H00118 | Congenital disorders of glycosylation (CDG) type I |
P34949
(related)
|
| H00409 | Type II diabetes mellitus |
P37231
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00720 | Long QT syndrome |
Q12809
(related)
|
| H00725 | Short QT syndrome |
Q12809
(related)
|
| H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
| H00094 | DNA repair defects |
Q13315
(related)
|
| H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
| H00296 | Defects in RecQ helicases |
Q14191
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
| H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|